{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T20:57:55Z","timestamp":1774213075916,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejmp.2023.102569","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T22:24:03Z","timestamp":1679955843000},"page":"102569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Does variable RBE affect toxicity risks for mediastinal lymphoma patients? NTCP-based evaluation after proton therapy treatment"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-9261","authenticated-orcid":false,"given":"Francesco","family":"Tommasino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-7279","authenticated-orcid":false,"given":"Giorgio","family":"Cartechini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9093-5939","authenticated-orcid":false,"given":"Roberto","family":"Righetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-2345","authenticated-orcid":false,"given":"Paolo","family":"Farace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cianchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2023.102569_b0005","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.2147\/OTT.S220730","article-title":"Proton therapy for lymphomas: current state of the art","volume":"12","author":"Ricardi","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ejmp.2023.102569_b0010","doi-asserted-by":"crossref","unstructured":"Taparra K, Lester SC, Harmsen WS, Petersen M, Funk RK, Blanchard MJ, et al. Reducing Heart Dose with Protons and Cardiac Substructure Sparing for Mediastinal Lymphoma Treatment. Int J Part Ther 2020;7:1\u201312. 10.14338\/IJPT-20-00010.1.","DOI":"10.14338\/IJPT-20-00010.1"},{"key":"10.1016\/j.ejmp.2023.102569_b0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijrobp.2017.05.014","article-title":"Consensus Guidelines for Implementing Pencil-Beam Scanning Proton Therapy for Thoracic Malignancies on Behalf of the PTCOG Thoracic and Lymphoma Subcommittee","volume":"99","author":"Chang","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0020","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2018-03-837633","article-title":"Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines","volume":"132","author":"Dabaja","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ejmp.2023.102569_b0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13014-019-1432-8","article-title":"Comparative photon and proton dosimetry for patients with mediastinal lymphoma in the era of Monte Carlo treatment planning and variable relative biological effectiveness","volume":"14","author":"Tseng","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13014-020-1462-2","article-title":"Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin\u2019s lymphoma. Assessment of risk of toxicity and secondary cancer induction","volume":"15","author":"Scorsetti","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2016.08.022","article-title":"Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clon.2021.12.007","article-title":"Model-based selection for proton therapy in breast cancer: development of the national indication protocol for proton therapy and first clinical experiences","volume":"34","author":"Boersma","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0050","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejmp.2023.102569_b0055","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1200\/JCO.2016.72.0722","article-title":"Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials","volume":"35","author":"Taylor","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/cancers7010353","volume":"7","author":"Tommasino","year":"2015","journal-title":"Proton Radiobiology Cancers (Basel)"},{"key":"10.1016\/j.ejmp.2023.102569_b0065","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aad9db","article-title":"Exploration and application of phenomenological RBE models for proton therapy","volume":"63","author":"R\u00f8rvik","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0070","doi-asserted-by":"crossref","first-page":"20190334","DOI":"10.1259\/bjr.20190334","article-title":"Modelling variable proton relative biological effectiveness for treatment planning","volume":"93","author":"McNamara","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ejmp.2023.102569_b0075","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1088\/0031-9155\/50\/12\/003","article-title":"The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer","volume":"50","author":"Tilly","year":"2005","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0080","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/0284186X.2017.1348625","article-title":"The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer","volume":"56","author":"\u00d6d\u00e9n","year":"2017","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ejmp.2023.102569_b0085","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1080\/0284186X.2017.1371325","article-title":"Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in \u03b1\/\u03b2","volume":"56","author":"Paganetti","year":"2017","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ejmp.2023.102569_b0090","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1080\/0284186X.2017.1373198","article-title":"Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer","volume":"56","author":"Pedersen","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0095","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ab2144","article-title":"Applying a variable relative biological effectiveness (RBE) might affect the analysis of clinical trials comparing photon and proton therapy for prostate cancer","volume":"64","author":"Marteinsdottir","year":"2019","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0100","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abd230","article-title":"The impact of variable relative biological effectiveness in proton therapy for left-sided breast cancer when estimating normal tissue complications in the heart and lung","volume":"66","author":"Marteinsdottir","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0105","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aadf24","article-title":"Impact of potentially variable RBE in liver proton therapy","volume":"63","author":"Chen","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0110","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijrobp.2020.03.013","article-title":"Late contrast enhancing brain lesions in proton-treated patients with low-grade glioma: clinical evidence for increased periventricular sensitivity and variable RBE","volume":"107","author":"Bahn","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2022.11.011","article-title":"Increased relative biological effectiveness and periventricular radiosensitivity in proton therapy of glioma patients","volume":"178","author":"Eulitz","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2020.08.058","article-title":"Brain necrosis in adult patients after proton therapy: is there evidence for dependency on linear energy transfer?","volume":"109","author":"Niemierko","year":"2021","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2021.08.015","article-title":"Study of relationship between dose, LET and the risk of brain necrosis after proton therapy for skull base tumors","volume":"163","author":"Garbacz","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0360-3016(02)02754-2","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy","volume":"53","author":"Paganetti","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102569_b0135","doi-asserted-by":"crossref","first-page":"R419","DOI":"10.1088\/0031-9155\/59\/22\/R419","article-title":"Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer","volume":"59","author":"Paganetti","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.radonc.2021.08.016","article-title":"Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?","volume":"163","author":"S\u00f8rensen","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0145","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.ijrobp.2013.05.005","article-title":"Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG)","volume":"89","author":"Specht","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102569_b0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2022.02.015","article-title":"Technical challenges in the treatment of mediastinal lymphomas by proton pencil beam scanning and deep inspiration breath-hold","volume":"169","author":"Righetto","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0155","doi-asserted-by":"crossref","first-page":"8399","DOI":"10.1088\/0031-9155\/60\/21\/8399","article-title":"A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data","volume":"60","author":"McNamara","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0160","doi-asserted-by":"crossref","first-page":"8601","DOI":"10.1088\/0031-9155\/60\/21\/8601","article-title":"Characterization and validation of a Monte Carlo code for independent dose calculation in proton therapy treatments with pencil beam scanning","volume":"60","author":"Fracchiolla","year":"2015","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0165","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.1118\/1.4758060","article-title":"TOPAS: an innovative proton Monte Carlo platform for research and clinical applications","volume":"39","author":"Perl","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.ejmp.2023.102569_b0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2021.04.007","article-title":"A systematic review on the usage of averaged LET in radiation biology for particle therapy","volume":"161","author":"Kalholm","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/0284186X.2021.1992007","article-title":"Towards harmonizing clinical linear energy transfer (LET) reporting in proton radiotherapy: a European multi-centric study","volume":"61","author":"Hahn","year":"2022","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ejmp.2023.102569_b0180","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/jrr\/rrs114","article-title":"Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation","volume":"54","author":"Friedrich","year":"2013","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ejmp.2023.102569_b0185","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/02841869309093594","article-title":"Quantitative clinical radiobiology","volume":"32","author":"S\u00f8rM","year":"1993","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ejmp.2023.102569_b0190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/095530000138448","article-title":"Quantitative clinical radiobiology of early and late lung reactions","volume":"76","author":"Bentzen","year":"2000","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ejmp.2023.102569_b0195","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1748-717X-7-224","article-title":"Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis","volume":"7","author":"Cella","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0200","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijrobp.2013.05.049","article-title":"Multivariate normal tissue complication probability modeling of heart valve dysfunction in hodgkin lymphoma survivors","volume":"87","author":"Cella","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2023.102569_b0205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.radonc.2015.07.051","article-title":"Modeling the risk of radiation-induced lung fibrosis: irradiated heart tissue is as important as irradiated lung","volume":"117","author":"Cella","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0215","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2015.10.004","article-title":"The quest for evidence for proton therapy: model-based approach and precision medicine","volume":"95","author":"Widder","year":"2016","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0220","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1080\/0284186X.2017.1299218","article-title":"Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery","volume":"56","author":"Tommasino","year":"2017","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ejmp.2023.102569_b0225","doi-asserted-by":"crossref","unstructured":"Fellin F, Iacco M, D\u2019Avino V, Tommasino F, Farace P, Palma G, et al. Potential skin morbidity reduction with intensity-modulated proton therapy for breast cancer with nodal involvement. Acta Oncol (Madr) 2019:1\u20139. 10.1080\/0284186X.2019.1591638.","DOI":"10.1080\/0284186X.2019.1591638"},{"key":"10.1016\/j.ejmp.2023.102569_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2019.09.015","article-title":"The meaningless meaning of mean heart dose in mediastinal lymphoma in the modern radiation therapy era","volume":"10","author":"Hoppe","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0235","first-page":"103","article-title":"Long-term toxicity of chemotherapy and radiotherapy in lymphoma survivors: optimizing treatment for individual patients","volume":"13","author":"Hodgson","year":"2015","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0240","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/annonc\/mds110","article-title":"Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin\u2019s lymphoma","volume":"23","author":"Sasse","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejmp.2023.102569_b0245","first-page":"67","article-title":"Modelling the HPRT-gene mutation induction of particle beams: systematicin vitrodata collection, analysis and microdosimetric kinetic model implementation","author":"Attili","year":"2022","journal-title":"Phys Med Biol"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179723000467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179723000467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:53:30Z","timestamp":1761105210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179723000467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":49,"alternative-id":["S1120179723000467"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2023.102569","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does variable RBE affect toxicity risks for mediastinal lymphoma patients? NTCP-based evaluation after proton therapy treatment","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2023.102569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102569"}}